FIVE PRIME THERAPEUTICS INC — Form D

FIVE PRIME THERAPEUTICS INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-03-26. The offering totals $21.0M, of which $21.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Brian G AtwoodDirectorGaithersburg, MD
Franklin M Berger, CFADirectorSouth San Francisco, CA
Fred E Cohen, M.D., D.Phil.DirectorSouth San Francisco, CA
R. Lee DouglasDirectorSouth San Francisco, CA
Peder K Jensen, M.D.DirectorSouth San Francisco, CA
Aron M KnickerbockerDirectorSouth San Francisco, CA
Mark D McDadeDirectorMenlo Park, CA
MARC L BELSKYExecutive OfficerSOUTH SAN FRANCISCO, CA
Julie L Hambleton, M.D.Executive OfficerSouth San Francisco, CA
W. Michael Kavanaugh, M.D.Executive OfficerSouth San Francisco, CA
Aron M KnickerbockerExecutive OfficerSouth San Francisco, CA
Francis W SarenaExecutive OfficerSouth San Francisco, CA
Julia P GregoryDirectorDartmouth, A5
Julia P GregoryExecutive OfficerDartmouth, A5
Lewis T WilliamsDirectorSouth San Francisco, CA
Lewis T WilliamsExecutive OfficerSouth San Francisco, CA
Robert Lee DouglasDirectorThe Woodlands, TX
Marc Michael BelskyExecutive OfficerSouth San Francisco, CA
Mark T McDadeDirectorSouth San Francisco, CA
Lauretta Michael CesarioExecutive OfficerSouth San Francisco, CA
W. Michael KavanaughExecutive OfficerSouth San Francisco, CA
Brian K AtwoodDirectorMenlo Park, CA
Peder K JensenDirectorSouth San Francisco, CA
Franklin T BergerDirectorSouth San Francisco, CA
Francis K SarenaExecutive OfficerSouth San Francisco, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2012-04-20D$10.0M$10.0M
2010-09-16D$7.5M$7.5M

More